Lazard's close relationship with Pfizer, the world's biggest drug company, has cost it an advisory role in Sanofi's €47.8bn ($59.6bn) hostile bid for Aventis.

The Paris office of Lazard has worked for both Sanofi and Aventis in the past and was keen to have a role in the deal, according to banking sources.